[Therapy of hypersomnia].

Rev Neurol (Paris)

Published: June 1967

Download full-text PDF

Source

Publication Analysis

Top Keywords

[therapy hypersomnia]
4
[therapy
1

Similar Publications

First Episode Psychosis in a Teen with Narcolepsy and Cataplexy.

Psychopharmacol Bull

January 2025

Abhishek Reddy, MD, Assistant Professor, Child and Adolescent Psychiatry, Sleep Medicine, Department of Psychiatry, Virginia Tech Carilion School of Medicine, Roanoke, VA, United States.

Article Synopsis
  • Narcolepsy with cataplexy (NT1) is a rare sleep disorder that can be linked to early-onset psychosis, particularly in kids and teens.
  • After excluding other medical issues, an adolescent girl with NT1 was initially diagnosed with a brief psychotic episode and treated with Risperidone.
  • Her symptoms improved significantly after switching to Chlorpromazine, marking one of the first successful uses of this drug for managing first-episode psychosis in a patient with NT1.
View Article and Find Full Text PDF

Background: Epidermolysis bullosa (EB) comprises a group of genetically and clinically heterogeneous diseases characterized by skin fragility and blistering. EB is incurable, and treatment consists of preventing blisters in addition to painful and time consuming skin care, often performed by the parents, in addition to monitoring other symptoms in cases of severe EB.

Results: The purpose of this study was to explore parental experiences of caring for a child with EB.

View Article and Find Full Text PDF

Background: Sleep disorders are a common health problem that can be classified into many types that are distinguished by their history and characteristics. In this case report, we discuss a case of a patient suffering from recurrent unusual prolonged sleep attacks lasting up to 9 days that responded excellently to levetiracetam.

Case Presentation: An 18-year-old Syrian male patient presented to the neurology department complaining of recurrent prolonged sleep episodes lasting for 9 days.

View Article and Find Full Text PDF
Article Synopsis
  • - KCNMA1-linked channelopathy leads to neurodevelopmental disorders, epilepsy, and non-epileptic episodes characterized by specific facial, behavioral, and physical symptoms.
  • - A review of 14 videos highlighted typical episode features: facial changes, behavioral arrest, loss of postural control, and quick recovery without drowsiness, with episodes often triggered by emotions.
  • - Distinguishing KCNMA1-related attacks from other conditions like paroxysmal dyskinesia and cataplexy will improve accurate diagnosis and targeted treatment for affected individuals.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aims to address the ongoing symptoms of depression, particularly focusing on residual hypersomnia, which significantly impacts daily life and is under-researched.
  • - A systematic review analyzed data from multiple databases to assess the prevalence and treatment options for residual hypersomnia in depression, finding that current treatments, including modafinil and CPAP for patients with sleep apnea, show limited long-term effectiveness.
  • - The research highlights challenges like unclear definitions and a lack of rigorous trials, emphasizing the need for more studies to improve the understanding and management of residual hypersomnia in depressed patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!